English PR-Wirein Press Release Reportedtimes Research Newswire

Pulmonary Arterial Hypertension Market is anticipated to grow at a CAGR of 5.77% from 2022 to 2028 globally – Axiom MRC

Pulmonary-Arterial-Hypertension-market

 

The factors such as advancement of the new technology, along with increasing burden of the pulmonary arterial hypertension as the prevalence and incidence of the PH based on the population has proven to be challenging due to the lack of the specificity of the diagnosis, and the private and government support for the development of the orphan drugs have been driving the growth of the pulmonary arterial hypertension market during the forecast period.

New York, March 2022: Axiom Market Research & Consulting™ added a report on Pulmonary Arterial Hypertension Market which includes study on drug class, type, diagnosis, treatment, end users, sales channel, and geography. Pulmonary Arterial Hypertension Market was projected to grow at a CAGR of 5.77% for the forecast period 2022 to 2028. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the pulmonary arterial hypertension market.

Get Sample PDF Copy @ https://www.axiommrc.com/rqs/10435-pulmonary-arterial-hypertension-market-report 

The report analyses the pulmonary arterial hypertension market based on drug class, type, diagnosis, treatment, end users, sales channel and geography. By drug class, the pulmonary arterial hypertension market is segmented into endothelin receptor antagonists (ERAs), prostacyclin and prostacyclin analogs, sGC stimulators, and PDE-5 dipsticks. By type, the pulmonary arterial hypertension market is segmented into idiopathic, heritable and associated. By diagnosis, the pulmonary arterial hypertension market is segmented into blood tests, chest X-Ray, electrocardiogram (ECG), echocardiogram, right heart catheterization, and polysomnogra. By treatment, the pulmonary arterial hypertension market is segmented into medication, surgery and therapy. By end users, the pulmonary arterial hypertension market is segmented into hospitals, specialty clinics and home healthcare. By sales channel, the pulmonary arterial hypertension market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. Geographically, the pulmonary arterial hypertension market is studied for the regions including North America, Europe, Asia Pacific, and Rest of the World.

The key players in the pulmonary arterial hypertension market are Arena Pharmaceuticals, Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline Plc, Johnson & Johnson (Actelion Pharmaceuticals, Ltd.), Merck & Co. Inc., Novartis International AG, Pfizer, Inc. and United Therapeutics Corporation among others.

Regional Trends of Pulmonary Arterial Hypertension Market

Based on the geography, the pulmonary arterial hypertension market is studied for the regions including North America, Europe, Asia Pacific and Rest of the World. North America is estimated to be the dominating region in the pulmonary arterial hypertension market during the forecast period. The increase in the healthcare expenditure and core manufacturing, along with the growing awareness about the pulmonary arterial hypertension and increasing diagnosis for the disease has been propelling the growth of the pulmonary arterial hypertension market in the region during the forecast period. Asia Pacific is expected to witness highest growth in the pulmonary arterial hypertension market during the forecast period. The increasing population, emerging economy and improving healthcare facilities and system has been driving the growth of the market in the region.

Pulmonary Arterial Hypertension Market Segmentation Highlights

  • Endothelin antagonists receptors (ERAs) drug class segment is estimated to have significant market share in the pulmonary arterial hypertension market during the forecast period. The advanced management of hypertension has been driving the growth of the segment in the market.
  • Idiopathic type segment is the major type of the disease observed in the pulmonary arterial hypertension market during the forecast period. The increasing demand of the idiopathic type has been driving the growth of the segment in the market.
  • Blood test diagnosis segment is mostly done to identify the disease in the pulmonary arterial hypertension market during the forecast period. The factor like easy availability and detection of the pulmonary disease has been driving the growth of the segment in the market.
  • Therapy treatment segment is widely used in the pulmonary arterial hypertension market during the forecast period. The wide use of the therapy treatment has been driving the growth of the segment during the forecast period.
  • Hospital end user segment is leading the pulmonary arterial hypertension market during the forecast period. The advanced services like the diagnosis tools and the facilities provided for treating the patients has been driving the growth of segment in the market.
  • Hospital pharmacy sales channel segment is leading the pulmonary arterial hypertension market during the forecast period. The professionalization of the functioning of the pharmaceutical services in the hospitals have been driving the growth of segment in the market.
  • North America is expected to dominate the pulmonary arterial hypertension market during the forecast period. The increase in the healthcare expenditure and core manufacturing has been driving the growth of the market in the region.

Purchase This Report @ https://www.axiommrc.com/buy_now/10435-pulmonary-arterial-hypertension-market-report 

Research Objectives of Pulmonary Arterial Hypertension Market Report:

  • Analysing the outlook of the pulmonary arterial hypertension market with the recent trends and Porter’s five forces analysis
  • Market dynamics, which essentially consider the factors that are impelling the present market scenario, along with growth prospects of the market over the forecast period
  • Market segmentation analysis, including qualitative and quantitative research, incorporating the impact of economic and non-economic aspects
  • Country-level analysis, integrating the demand and supply forces that are influencing the growth of the pulmonary arterial hypertension market
  • Competitive landscape involving the market share of major players, along with the key strategies adopted for development over the past five years
  • Comprehensive company profiles, covering the product offerings, key financial information, recent developments and strategies employed by the major market players

Our Other Related Reports:

Cardiac Implants Market Report :

https://www.axiommrc.com/product/hc1765-cardiac-implants-market-report 

Structural Heart Devices Market Report :

https://www.axiommrc.com/product/hc1883-structural-heart-devices-market-report 

About Us:

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc.

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 700+ Market Research Projects, 2100+ Data Analytics Projects, 260+ Business Support Projects and has a 400+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.

For more information, visit Axiom Market Research & Consulting™ at www.axiommrc.com

Tags: Pulmonary Arterial Hypertension Analysis, Pulmonary Arterial Hypertension Market Share, Pulmonary Arterial Hypertension Share, Pulmonary Arterial Hypertension Market growth, Pulmonary Arterial Hypertension Market analysis, Pulmonary Arterial Hypertension Market, Pulmonary Arterial Hypertension Forecast, Pulmonary Arterial Hypertension Growth, Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Market Trend

See Campaign: https://www.axiommrc.com/product/10435-pulmonary-arterial-hypertension-market-report

Contact Information:

Axiom Market Research & Consulting United States 3 Germany Dr.Ste 4 – 4666 Wilmington DE 19804 + 1 (845) 875-9786 U.K.:- + 44 (0) 20 3286 9707 Email: sales@axiommrc.com  Website: https://www.axiommrc.com

Tags:
PR-Wirein, Reportedtimes, Research Newswire, English

Contact Information:

Axiom Market Research & Consulting
United States
3 Germany Dr.Ste 4 – 4666
Wilmington DE 19804
+ 1 (845) 875-9786
U.K.:- + 44 (0) 20 3286 9707
Email: sales@axiommrc.com 
Website: https://www.axiommrc.com

Add Comment

Click here to post a comment

Your email address will not be published. Required fields are marked *